OFM
Omega Fund Management Portfolio holdings
AUM
$154M
This Quarter Return
-8.52%
1 Year Return
-32.78%
3 Year Return
+82.35%
5 Year Return
+29.08%
10 Year Return
+90.46%
AUM
$135M
AUM Growth
+$135M
(-13%)
Cap. Flow
+$213K
Cap. Flow
% of AUM
0.16%
Top 10 Holdings %
Top 10 Hldgs %
99.72%
Holding
12
New
1
Increased
–
Reduced
3
Closed
1
Top Buys
| 1 |
ALMS
Alumis Inc. Common Stock
ALMS
|
$8.69M |
Top Sells
| 1 |
Replimune Group
REPL
|
$4.86M |
| 2 |
Nuvation Bio
NUVB
|
$2.33M |
| 3 |
KRON
Kronos Bio
KRON
|
$1.24M |
| 4 |
enGene Holdings Inc. Warrants
ENGNW
|
$46.9K |
Sector Composition
| 1 | Healthcare | 99.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Nuvation Bio
NUVB
$1.02B
| $38.8M | 28.72% | 13,275,884 -796,456 | -6% | -$2.33M |
|
2
Lexeo Therapeutics
LXEO
$259M
| $37.8M | 28% | 2,355,904 | – | – |
|
|
3
Replimune Group
REPL
$422M
| $22.2M | 16.41% | 2,461,319 -540,000 | -18% | -$4.86M |
|
|
4
enGene Holdings
ENGN
$236M
| $10.2M | 7.52% | 1,076,357 | – | – |
|
|
ALMS
5
Alumis Inc. Common Stock
ALMS
$479M
| $8.69M | 6.44% | +653,225 | New | +$8.69M |
|
|
MORF
6
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $5.45M | 4.03% | 159,846 | – | – |
|
7
Sana Biotechnology
SANA
$777M
| $4.61M | 3.41% | 843,750 | – | – |
|
|
IMA
8
ImageneBio, Inc. Common Stock
IMA
$150M
| $3.71M | 2.75% | 2,249,123 | – | – |
|
9
Immunic
IMUX
$80.9M
| $1.98M | 1.47% | 1,788,160 | – | – |
|
|
SYRS
10
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $1.3M | 0.96% | 251,270 | – | – |
|
|
11
enGene Holdings Inc. Warrants
ENGNW
$7.08M
| $383K | 0.28% | 321,502 -39,401 | -11% | -$46.9K |
|
|
KRON
12
DELISTED
Kronos Bio
KRON
| – | – | -955,866 | Closed | -$1.24M |
|